<SEC-DOCUMENT>0001104659-20-081356.txt : 20200707
<SEC-HEADER>0001104659-20-081356.hdr.sgml : 20200707
<ACCEPTANCE-DATETIME>20200706173845
ACCESSION NUMBER:		0001104659-20-081356
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200707
DATE AS OF CHANGE:		20200706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239506
		FILM NUMBER:		201014438

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		203 787 7888

	MAIL ADDRESS:	
		STREET 1:		4 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>tm2024208d1_s1a.htm
<DESCRIPTION>FORM S-1/A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on July 6, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;333-239506&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-EFFECTIVE AMENDMENT NO.
1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>UNDER </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>THE SECURITIES ACT OF 1933</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRECIPIO, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>3826</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1789357</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction of</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>incorporation or organization)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Primary Standard Industrial</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Classification Code Number)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification Number)</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4 Science Park </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New Haven, Connecticut 06511 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(203) 787-7888 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address, including zip code and telephone
number, including area code, of registrant&rsquo;s principal executive offices) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ilan Danieli </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Executive Officer </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Precipio, Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4 Science Park </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New Haven, Connecticut 06511 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(203) 787-7888 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, address, including zip code and
telephone number, including area code, of agent for service) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Thomas A. Rose </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sichenzia Ross Ference LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1185 Avenue of the Americas, 37th&nbsp;Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 930-9700</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Approximate date of commencement of proposed sale to the
public:</B> As soon as practicable after this registration statement becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any of the securities being registered on this Form are to
be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is filed to register additional securities for
an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this Form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging
growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 29%"><FONT STYLE="font-size: 10pt">Large&nbsp;Accelerated&nbsp;Filer</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 29%"><FONT STYLE="font-size: 10pt">Accelerated&nbsp;Filer</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Non-Accelerated Filer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Smaller&nbsp;Reporting&nbsp;Company</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Emerging Growth Company</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><BR>
<FONT STYLE="font-size: 10pt"><B>Title of Each Class of<BR>
Securities to be Registered</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposed<BR>
Maximum<BR>
Aggregate<BR>
Offering&nbsp;Price(1)</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><BR>
<FONT STYLE="font-size: 10pt"><B>Amount of<BR>
Registration&nbsp;Fee(2)</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 64%"><FONT STYLE="font-size: 10pt">Common Stock, $0.01 par value per share</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 15%; text-align: right"><FONT STYLE="font-size: 10pt">5,085,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 15%; text-align: right"><FONT STYLE="font-size: 10pt">660.03<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) Estimated solely for the purpose of calculating the registration
fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) Calculated pursuant to Rule 457(o) based on an estimate
of the proposed maximum aggregate offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3) The Registrant previously paid $660.03 of the total registration
fee in connection with the filing of Registration Statement on Form S-1 filed on June 26, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"><B>The registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a)
of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting
pursuant to said Section&nbsp;8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;<IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;13. <I>Other Expenses of Issuance and Distribution</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth all expenses, other than the
underwriting discounts and commissions, payable by the registrant in connection with the sale of the common stock being registered.
All the amounts shown are estimates except the SEC registration fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 87%"><FONT STYLE="font-size: 10pt">SEC registration fee</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">660</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Printing and engraving expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Legal fees and expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Accounting fees and expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Transfer agent and registrar fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Miscellaneous</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">1,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">25,660</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;14. <I>Indemnification of Directors and Officers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section&nbsp;145(a) of the Delaware General Corporation Law
(the &ldquo;DGCL&rdquo;) provides, in general, that a corporation shall have the power to indemnify any person who was or is a
party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of the corporation), by reason of the fact he or she is
or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including
attorneys&rsquo; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection
with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable
cause to believe his or her conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 145(b) of the DGCL provides, in general, that a corporation
shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending
or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was
a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including
attorneys&rsquo; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action
or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests
of the corporation, except that no indemnification shall be made with respect to any claim, issue or matter as to which he or she
shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating
court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is
fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or other adjudicating court shall deem
proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 145(g) of the DGCL provides, in general, that a corporation
shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred
by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the
power to indemnify the person against such liability under Section 145 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 9.1 of Article IX of the Registrant&rsquo;s Third Amended
and Restated Certificate of Incorporation, as amended to date (the &ldquo;Certificate of Incorporation&rdquo;), and Section 1 of
Article V of the Registrant&rsquo;s Amended and Restated Bylaws, as amended to date (the &ldquo;Bylaws&rdquo;) provide that each
person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (hereinafter a &ldquo;proceeding&rdquo;), by reason of the fact that he
or she is or was a director or officer of the Registrant or is or was serving at the request of the Registrant as a director or
officer of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to
employee benefit plans (hereinafter an &ldquo;indemnitee&rdquo;), whether the basis of such proceeding is alleged action in an
official capacity as a director or officer or in any other capacity while serving as a director or officer, shall be indemnified
and held harmless by the Registrant to the fullest extent authorized by the General Corporation Law of the State of Delaware, as
the same exists or may thereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits
the Registrant to provide broader indemnification rights than such law permitted the Registrant to provide prior to such amendment),
against all expense, liability and loss (including attorneys&rsquo; fees, judgments, fines, excise taxes or penalties and amounts
paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith and that such indemnification shall
continue as to an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the indemnitee&rsquo;s
heirs, executors and administrators; provided, however, that, except as otherwise provided in the Certificate of Incorporate or
Bylaws, as applicable, the Registrant will indemnify any such indemnitee in connection with a proceeding initiated by such indemnitee
only if such proceeding was authorized by the Board of Directors of the Registrant. The right to indemnification conferred by the
Certificate of Incorporation and Bylaws is a contract right and includes the right to be paid by the Registrant the expenses incurred
in defending any such proceeding in advance of its final disposition (hereinafter an &ldquo;advancement of expenses&rdquo;); and
provided, further, that, if the General Corporation Law of the State of Delaware requires it, an advancement of expenses incurred
by an indemnitee shall be made only upon delivery to the Registrant of an undertaking, by or on behalf of such indemnitee, to repay
all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to
appeal that such indemnitee is not entitled to be indemnified for such expenses under the Certificate of Incorporation or Bylaws,
as applicable, or otherwise (hereinafter an &ldquo;undertaking&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 9.2 of Article IX of the Certificate of Incorporation
and Section 2 of Article V of the Bylaws provide that if a claim under Section 9.1 of Article IX of the Certificate of Incorporation
or under Section 1 of Article V of the Bylaws, as applicable, is not paid in full by the Registrant within sixty (60) days after
a written claim has been received by the Registrant, except in the case of a claim for an advancement of expenses, in which case
the applicable period shall be twenty (20) days, the indemnitee may at any time thereafter bring suit against the Registrant to
recover the unpaid amount of the claim. If successful in whole or part in any such suit, the indemnitee shall be entitled to be
paid also the expense of prosecuting or defending such suit. In any suit brought by the indemnitee to enforce a right to indemnification
hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses), it shall be a defense
that the indemnitee has not met the applicable standard of conduct set forth in the General Corporation Law of the State of Delaware.
Likewise, in any suit by the Registrant to recover an advancement of expenses pursuant to the terms of an undertaking, the Registrant
shall be entitled to recover such expenses upon a final adjudication that the indemnitee has not met such standards. Neither the
failure of the Registrant (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination
prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee
has met the applicable standard of conduct set forth in the General Corporation Law of the State of Delaware, nor an actual determination
by the Registrant (including its Board of Directors, independent legal counsel or its stockholders) that the indemnitee has not
met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of
conduct or, in the case of such a suit brought by indemnitee, be a defense to such suit. In any suit brought by the indemnitee
to enforce a right under such indemnification provisions of the Certificate of Incorporation or Bylaws, as applicable, or by the
Registrant to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee
is not entitled to be indemnified or to such advancement of expenses shall be on the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant has entered into indemnification agreements with
each of its directors and executive officers, in addition to the indemnification provisions provided for in its charter documents,
and the Registrant intends to enter into indemnification agreements with any new directors and executive officers in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant also maintains a directors&rsquo; and officers&rsquo;
liability insurance policy that insures the Registrant&rsquo;s directors and officers against such liabilities as are customarily
covered by such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;15. <I>Recent Sales of Unregistered Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the past three years, we have sold and issued the following
unregistered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We issued&nbsp;unregistered&nbsp;securities&nbsp;in
connection with the Merger as previously disclosed and included in our 10-Q filed on August 22, 2017, November 20, 2017, and 8-Ks
filed on February 2, 2017 and June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January 20, 2015, the Company entered
into a series of Unsecured Convertible Promissory Notes with seven accredited investors in the principal amount of $925,000. The
Company also issued, to its placement agent for the notes, a convertible promissory note, upon the same terms and conditions as
the notes, in an aggregate principal amount equal to 5% of the proceeds received by the Company, or $46,250. The notes are convertible
into shares of the Company&rsquo;s common stock. On January 13, 2017, all but one investor exercised their conversion rights relating
to their respective notes, including the agent&rsquo;s note, and agreed to convert an aggregate amount of&nbsp;$499,359 of principal
and interest due under the notes and agent&rsquo;s note into 925 shares of the Company&rsquo;s common stock. On January 17, 2017,
the non-converting investor agreed to extend the maturity date of its note pursuant to an amendment that provides for two-thirds
of the outstanding principal amount of the note must be paid upon the earlier to occur of the close of the Merger with Precipio
Diagnostics, LLC or June 16, 2017 (such applicable date, the &ldquo;Deferred Maturity Date&rdquo;).&nbsp; On June 21 2017, the
non-converting investor agreed to further extend the Deferred Maturity Date of the note until the earlier <FONT STYLE="background-color: white">to
occur of (1) the closing of a public offering by the Company of either common stock, convertible preferred stock or convertible
preferred notes or (2) August 16, 2017. </FONT>On August&nbsp;31, 2017, the Company made payment of two-thirds of the then outstanding
principal amount, which was more than 10&nbsp;days after the Deferred Maturity Date and constituted an event of default under the
terms of the Note. The non-converting investor agreed to waive the event of default under the Note and in consideration of this
waiver, the Company issued the non-converting investor warrant to purchase 666 shares of the Company&rsquo;s common stock, par
value $0.01 per share. The balance was satisfied by the issuance to the non-converting investor of registered common shares on
February 12, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 13, 2017,
Transgenomic completed the sale of the promissory notes in the amount of $1.2 million and the issuance of warrants to acquire 2,667
shares of the Company's common stock at an exercise price of $225 per share, subject to anti-dilution protection. Aegis capital
Corp. acted as placement agent for the bridge financing and received warrants to acquire 373 shares of Transgenomic common stock
at an exercise price of $225.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 31, 2017, the Company entered
into a Debt Settlement Agreement with certain of its accounts payable creditors and in connection with the settlement, the Company
agreed to issue to certain of the creditors, namely Paul Hasting LLP, Mount Sinai, Montefiore Medical Center and Allergan Sales
LLC, warrants to purchase approximately 7,207 shares of the Company&rsquo;s common stock at an exercise price of $112.50 per share.
The warrants are exercisable on the date of issuance and will expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 20, 2018, the Company entered into
a securities purchase agreement (the &ldquo;Debt Financing Agreement&ldquo;) with Osher Capital Partners LLC, M2B Funding Corp
and Alpha Capital Anstalt pursuant to which the Company issued up to approximately $3,296,703 in 8% Senior Secured Convertible
Promissory Notes with 100% common stock warrant coverage. The transaction consists of unregistered 8% Senior Secured Convertible
Notes bearing interest at a rate of 8.00% annually and an original issue discount of 9%. The initial notes were convertible at
a price of $7.50 per share, provided that if the note is not repaid within 180 days, the conversion price shall be adjusted to
80% of the lowest volume weighted average price during the prior 10 days, subject to a minimum conversion price of $4.50 per share.
The transaction consisted of multiple drawdowns between April 20, 2018 and September 20, 2018. In aggregate, the closings provided
the Company with $3,000,000 of gross proceeds for the issuance of notes with an aggregate principal of $3,296,703. The notes are
payable by the Company on the earlier of (i) the one year anniversary of each note&rsquo;s closing date or (ii) upon the closing
of a qualified offering, namely the Company raising gross proceeds of at least $7,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 7, 2018, we issued the 40,000
Commitment Shares to Lincoln Park, as further discussed herein. The Commitment Shares were issued to Lincoln Park in accordance
with the terms of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On November 29,
2018, we entered into an amendment and restatement agreement (the &ldquo;Amendment Agreement&rdquo;) amending and restating the
terms of the Debt Financing Agreement. The Amendment Agreement provided for the issuance of up to $1,318,681 of additional notes
together with applicable warrants, in one or more tranches, on substantially the same terms and conditions as the notes and warrants
granted in connection with the Debt Financing Agreement, subject to certain adjustments to their terms. For the notes issued under
the Debt Financing Agreement as well as the notes issued pursuant to the Amendment Agreement, the conversion price in effect on
any conversion date has been amended so that it shall be equal to the greater of $3.75 or $0.75 above the closing bid price of
our common stock on the date prior to the original issue date. In the event the notes are not paid in full prior to 180 days after
the original issue date, the conversion price shall be equal to 80% of the lowest VWAP in the 10 trading days prior to the date
of the notice of conversion, but in no event below the floor price of $2.25. In aggregate, the notes issued under the Amendment
Agreement provided the Company with $1,100,000 of gross proceeds for the issuance of Notes with an aggregate principal of $1,208,791
and the Company issued to the investors 300,115 warrants to purchase shares of common stock of the Company with an exercise price
of $5.40 and a five-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 17, 2018, October 23, 2018
and November 7, 2018 we entered into an Exchange Agreements (the &ldquo;Exchange Agreements&rdquo;) with three institutional investors
pursuant to which we agreed to issue promissory notes, due January 1, 2021 in exchange for amounts owed to certain vendors pursuant
to certain debt settlement agreements, dated October 31, 2017. The Exchange was being made in reliance upon the exemption from
registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended. Under the Exchange Agreements, we exchanged
up to an aggregate principal amount of $3,165,903 due under the debt settlement agreements for convertible notes totaling $2,765,568.
Pursuant to the terms of the notes, we shall pay to the noteholders the aggregate principal amount of the notes in eighteen (18)
equal installments beginning on August 1, 2019 and ending on January 1, 2021. In accordance with the terms of the notes, the noteholders
shall have the right, to convert at the then applicable conversion price any amount of the notes up to $300,000 on any given trading
day, with a maximum conversion amount up to $500,000 during a period of five (5) trading days. The conversion price shall be the
lesser of (i) the average volume average weighted price for the five trading days prior to the date of conversion multiplied by
1.65 and (ii) $15.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On March 12, 2018,
we entered into a settlement agreement (the &ldquo;Crede Agreement&rdquo;) with Crede Capital Group LLC (&ldquo;Crede&rdquo;) pursuant
to which we agreed to pay to Crede a total sum of $1.925 million (the &ldquo;Settlement Amount&rdquo;) over a period of 16 months
payable in a combination of cash and stock in accordance with terms contained in the Crede Agreement. On January 15, 2019, we entered
into an amendment and restatement agreement with Crede (the &ldquo;Crede Amendment&rdquo;), in order to enable us to provide Crede
with an alternative means of payment of the Settlement Amount, which was $1.45 million on the date of the Crede Amendment, by issuing
to Crede a convertible note in the amount of $1,450,000 (the &ldquo;Crede Note&rdquo;). The Crede Note was issued on January 15,
2019, as amended and restated on January 28, 2019, and is payable by the Company on the earlier of (i) the two year anniversary
after the original issuance date or (ii) upon the closing of a qualified offering, namely the Company raising gross proceeds of
at least $4,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On January 29,
2019, we entered into a settlement agreement with Leviston (the &ldquo;Leviston Agreement&rdquo;), at which time we issued to Leviston
a convertible note in the amount of $700,000 (the &ldquo;Leviston Note&rdquo;). The Leviston Note is payable by the Company (i)
in fourteen equal monthly installments commencing on the earlier to occur of (x) the last day of the month upon which a registration
statement to be filed by the Company covering the resale of the shares of common stock underlying the Note is declared effective
by the Securities and Exchange Commission and (y) the six month anniversary of the date of issuance, (ii) upon the closing of a
qualified offering, namely the Company raising gross proceeds of at least $4,000,000 or (iii) such earlier date as the Leviston
Note is required or permitted to be repaid as provided by the terms of the Leviston Note. The Company, at its option, may redeem
some or all of the then outstanding principal amount of the Leviston Note for cash. The conversion price of the Leviston Note in
effect on any Conversion Date shall equal the VWAP of the Common Stock on the date of Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 16, 2019,
the Company entered into an amendment and restatement agreement (&ldquo;Amendment No.2 Agreement&rdquo;) amending and restating
the terms of the Securities Purchase Agreement dated April 20, 2018 (as first amended pursuant to the Amendment Agreement dated
November 29, 2018). The Amendment No.&nbsp;2 Agreement&nbsp;provided the Company with approximately $900,000 of gross proceeds
for the issuance of notes with an aggregate principal of approximately $989,011 (the &ldquo;April 2019 Bridge Notes&rdquo;) together
with applicable warrants, with substantially the same terms and conditions as the previously issued bridge notes and related warrants.
In connection with the April 2019 Bridge Note issuances, the Company issued to the investors 147,472 warrants to purchase shares
of common stock of the Company with a five year term and exercise price of $5.40. The April 2019 Bridge Notes were issued to investors&nbsp;that
previously participated in the April 20, 2018 Securities Purchase Agreement. Pursuant to the Amendment No.2 Agreement, the warrants
issued pursuant to the Securities Purchase Agreement dated April 20, 2018 (as amended from time to time) were amended such that
the exercise price of such warrants was amended from $7.50 to $5.40 and any warrant that had a one-year term was amended to have
a five-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 14, 2019, the
Company entered into a Securities Purchase Agreement pursuant to which the Company was provided with approximately $1,000,000 of
gross proceeds for the issuance of notes with an aggregate principal of approximately $1,098,901 (the &ldquo;May 2019 Bridge Notes&rdquo;)
together with applicable warrants, with substantially the same terms and conditions as the previously issued bridge notes and related
warrants that were issued in connection with the Securities Purchase Agreement dated April 20, 2018 (as amended from time to time).
In connection with the May 2019 Bridge Note issuances, the Company issued to the investors 154,343 warrants to purchase shares
of common stock of the Company with a five year term and exercise price of $9.56. The May 2019 Bridge Notes were issued to investors&nbsp;that
previously participated in the Securities Purchase Agreement dated April 20, 2018.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise stated
above, the issuance of the above securities was deemed to be exempt from the registration requirements of the Securities Act by
virtue of Section 4(a)(2) thereof, as a transaction by an issuer not involving a public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 26, 2020,
the Company entered into an amendment agreement (the &ldquo;March 2020 Amendment&rdquo;) amending the terms of that certain Amendment
No. 2 Agreement dated April 16, 2019 and the securities purchase agreement dated May 14, 2019. As a result of the March 2020 amendment,
(i) the maturity date of the April 2019 Bridge Notes and the May 2019 Bridge Notes was extended three months from April 16, 2020
to July 16, 2020, (ii) the floor price at which conversions may occur under the April 2019 Bridge Notes and the May 2019 Bridge
Notes was amended from $2.25 to $0.40, and (iii) guaranteed interest on the April 2019 Bridge Notes and the May 2019 Bridge Notes
was amended from twelve months to eighteen months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;16. <I>Exhibits and Financial Statement Schedules</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(a)&nbsp;Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The exhibits to the registration statement are listed in the
Exhibit Index to this registration statement and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(b)&nbsp;Financial Statement Schedule.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;17. <I>Undertakings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.2pt; text-indent: 0.3pt">(i)&nbsp;&nbsp;&nbsp;To include
any prospectus required by Section 10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.2pt; text-indent: 0.3pt">(ii)&nbsp;&nbsp;To reflect in
the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the
 &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.2pt">(iii) To include any material information with respect
to the plan of distribution not previously disclosed in the registration statement or any material change to such information in
the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><I>Provided, however</I>, that paragraphs
(a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if the information required to be included in a post-effective amendment by
those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or 15(d) of
the Exchange Act that are incorporated by reference in the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual report pursuant to Section
13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report
pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions,
or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant hereby undertakes that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) The Registrant will provide to the underwriter at the closing
as specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the
underwriter to permit prompt delivery to each purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b) For purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A
and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities
Act shall be deemed to be part of this registration statement as of the time it was declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c) For the purpose of determining any liability under the Securities
Act each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating
to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933,
as amended, the Registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned,
thereunto duly authorized, on the 6<SUP>th</SUP> day of July, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">PRECIPIO, INC.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ilan Danieli</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Ilan Danieli</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="POA"></A><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each person whose individual signature appears below hereby
authorizes and appoints Ilan Danieli and Carl Iberger, and each of them, with full power of substitution and resubstitution and
full power to act without the other, as his or her true and lawful attorney in fact and agent to act in his or her name, place
and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file
any and all amendments to this Registration Statement, including any and all post effective amendments and amendments thereto,
and any registration statement relating to the same offering as this Registration Statement that is to be effective upon filing
pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys in fact and agents,
and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said
attorneys in fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933,
as amended, this Registration Statement has been signed by the following persons in the capacities indicated below on the 6<SUP>th</SUP>
day of July, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 30%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ilan Danieli</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chief Executive Officer and Director (Principal</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Ilan Danieli</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Executive Officer)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Carl Iberger</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chief Financial Officer (Principal Financial</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Carl Iberger</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Officer and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Douglas Fisher, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Douglas Fisher, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Kathleen LaPorte</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Kathleen LaPorte</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Mark Rimer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Mark Rimer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Richard Sandberg</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Richard Sandberg</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jeffrey Cossman, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Jeffrey Cossman, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David Cohen</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">David Cohen</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420416127921/v450427_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">2.1</FONT></A></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 93%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420416127921/v450427_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Agreement and Plan of Merger, dated October&nbsp;12, 2016 by and among Transgenomic,&nbsp;Inc., New Haven Labs&nbsp;Inc. and Precipio Diagnostics, LLC (incorporated by reference to Exhibit&nbsp;2.1 of the Company&rsquo;s Form&nbsp;8-K filed on October&nbsp;13, 2016). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">2.2</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">First Amendment to Agreement and Plan of Merger, dated as of February&nbsp;3, 2017 by and among Transgenomic,&nbsp;Inc., New Haven Labs&nbsp;Inc. and Precipio Diagnostics, LLC (incorporated by reference to Exhibit&nbsp;2.1 of the Company&rsquo;s Form&nbsp;8-K filed on February&nbsp;2, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">2.3</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Second Amendment to Agreement and Plan of Merger, dated as of June&nbsp;27, 2017 by and among Transgenomic,&nbsp;Inc., New Haven Labs&nbsp;Inc. and Precipio Diagnostics, LLC (incorporated by reference to Exhibit&nbsp;2.1 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.1</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Third Amended and Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit&nbsp;3.1 of the Company&rsquo;s 8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.2</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.3</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035085/v470106_ex3-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certificate of Elimination (incorporated by reference to Exhibit&nbsp;3.3 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517274394/d449841dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.4</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517274394/d449841dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certificate of Designation for Series&nbsp;B Preferred Stock (incorporated by reference to Exhibit&nbsp;3.1 of the Company&rsquo;s Form&nbsp;8-K filed on August&nbsp;31, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.5</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certificate of Designation for Series&nbsp;C Preferred Stock (incorporated by reference to Exhibit&nbsp;3.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;6, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003368/ex-3d1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.6</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003368/ex-3d1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certificate of Amendment to Third Amended and Restated Certificate of Incorporation dated April 25, 2019 (incorporated by reference to Exhibit 3.1 of the Company&rsquo;s Form 8-K filed on April 26, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000091205700010980/0000912057-00-010980.txt"><FONT STYLE="font-size: 10pt">4.1</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000091205700010980/0000912057-00-010980.txt"><FONT STYLE="font-size: 10pt">Form&nbsp;of Certificate of the Company&rsquo;s Common Stock (incorporated by reference to Exhibit&nbsp;4 of the Company&rsquo;s Registration Statement on Form&nbsp;S-1 (Registration No.&nbsp;333-32174) filed on March&nbsp;10, 2000). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.2</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Offering Warrant (incorporated by reference to Exhibit&nbsp;4.1 of the Company&rsquo;s Form&nbsp;8-K filed on August&nbsp;23, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex42.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.3</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex42.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Underwriter Warrant (incorporated by reference to Exhibit&nbsp;4.2 of the Company&rsquo;s Form&nbsp;8-K filed on August&nbsp;23, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex43.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.4</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex43.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Conversion Warrant (incorporated by reference to Exhibit&nbsp;4.3 of the Company&rsquo;s Form&nbsp;8-K filed on August&nbsp;23, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.5</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Warrant (incorporated by reference to Exhibit&nbsp;4.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;6, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.6</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex41.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Warrant (incorporated by reference to Exhibit&nbsp;4.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;13, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tm2024208d1_ex5-1.htm"><FONT STYLE="font-size: 10pt">5.1</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="tm2024208d1_ex5-1.htm"><FONT STYLE="font-size: 10pt">Opinion Sichenzia Ross Ference LLP</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312509225751/dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.1</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312509225751/dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">License Agreement between the Company and Dana-Farber Cancer Institute dated October&nbsp;8, 2009 (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;10-Q filed on November&nbsp;5, 2009). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417002477/v457058_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.2</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417002477/v457058_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Waiver Letter Agreement by and among the Company, Potomac Capital Partners,&nbsp;L.P., MAZ Partners, LP, David Wambeke and Craig-Hallum Capital Group, LLC dated as of January&nbsp;10, 2017 (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on January&nbsp;17, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417003207/v457303_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.3</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417003207/v457303_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">First Amendment to Unsecured Convertible Promissory Note&nbsp;by and among the Company and MAZ Partners LP, dated as of January&nbsp;17, 2017 (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on January&nbsp;20, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.4</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Termination and Tenth Amendment to Loan and Security Agreement, dated as of February&nbsp;3, 2017, by and among Third Security Senior Staff 2008 LLC, as administrative agent and a lender, the other lenders party thereto and the Company (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on February&nbsp;2, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.5</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417005965/v458392_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Promissory Note, dated February&nbsp;2, 2017 between the Company and Precipio Diagnostics, LLC (incorporated by reference to Exhibit&nbsp;10.2 of the Company&rsquo;s Form&nbsp;8-K filed on February&nbsp;3, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.6</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement, dated as of April&nbsp;13, 2017 by and between the Company and the investors set forth on Schedule A attached thereto (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on April&nbsp;17, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.7</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Promissory Note, issued by the Company to certain investors, dated as of April&nbsp;13, 2017 (incorporated by reference to Exhibit&nbsp;10.2 to the Company&rsquo;s Form&nbsp;8-K filed on April&nbsp;17, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.8</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Warrant to Purchase Common Stock, issued by the Company to certain investors, dated as of April&nbsp;13, 2017 (incorporated by reference to Exhibit&nbsp;10.3 of the Company&rsquo;s Form&nbsp;8-K filed on April&nbsp;17, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.9</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Precipio Diagnostics, LLC Subordinated Promissory Note, issued by Precipio to the Company, dated as of April&nbsp;13, 2017 (incorporated by reference to Exhibit&nbsp;10.4 of the Company&rsquo;s Form&nbsp;8-K filed on April&nbsp;17, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.10</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417020598/v464291_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Subordination Agreement, dated as of April&nbsp;13, 2017, by and between the Company and Webster Bank, National Association (incorporated by reference to Exhibit&nbsp;10.5 of the Company&rsquo;s Form&nbsp;8-K filed on April&nbsp;17, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034456/v469847_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.11</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034456/v469847_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Side Letter to extend Maturity Date of Unsecured Convertible Promissory Note&nbsp;by and between the Company and MAZ Partners LP, dated as of June&nbsp;21, 2017 (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;27, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417065873/tv482289_def14a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.12&dagger;</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417065873/tv482289_def14a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amended and Restated 2017 Stock Option and Incentive Plan (incorporated by reference to Annex D of the Company&rsquo;s Definitive Proxy Statement on Schedule 14A filed on December&nbsp;29, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.13&dagger;</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Non-Qualified Stock Option Agreement for Non-Employee Directors (incorporated by reference to Exhibit&nbsp;10.2 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;28, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.14&dagger;</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Non-Qualified Stock Option Agreement for Company Employees (incorporated by reference to Exhibit&nbsp;10.3 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;28, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.15&dagger;</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417034670/v469811_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Incentive Stock Option Agreement (incorporated by reference to Exhibit&nbsp;10.4 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;28, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.16</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement with the Private Placement Purchasers (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.17</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Investors&rsquo; Rights Agreement (incorporated by reference to Exhibit&nbsp;10.2 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.18</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Exchange Agreement (incorporated by reference to Exhibit&nbsp;10.3 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.19</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">New Bridge Securities Purchase Agreement (incorporated by reference to Exhibit&nbsp;10.4 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.20</FONT></A></TD>
    <TD STYLE="width: 1%; padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 93%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of New Bridge Promissory Note&nbsp;(incorporated by reference to Exhibit&nbsp;10.5 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.21</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of New Bridge Warrant (incorporated by reference to Exhibit&nbsp;10.6 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.22</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420417035081/v470091_ex10-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of Side Warrant (incorporated by reference to Exhibit&nbsp;10.7 of the Company&rsquo;s Form&nbsp;8-K filed on June&nbsp;30, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517242559/d385198dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.23#</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517242559/d385198dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amended and Restated Pathology Services Agreement, dated March&nbsp;21, 2017, by and between the Company and Yale University (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K/A filed on July&nbsp;31, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517242559/d385198dex102.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.24</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517242559/d385198dex102.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Lease, dated July&nbsp;11, 2017, by and between the Company and Science Park Development Corporation (incorporated by reference to Exhibit&nbsp;10.2 of the Company&rsquo;s Form&nbsp;8K/A filed on July&nbsp;31, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.25</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884dex11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Underwriting Agreement, dated August&nbsp;22, 2017, by and among the Company and the underwriters party thereto (incorporated by reference to Exhibit&nbsp;1.1 of the Company&rsquo;s Form&nbsp;8-K filed on August&nbsp;23, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517332004/d486748dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.26</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517332004/d486748dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Placement Agency Agreement, dated as of November&nbsp;2, 2017, by and between Precipio,&nbsp;Inc. and Aegis Capital Corp. (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;3, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.27</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Debt Settlement Agreement, dated October&nbsp;31, 2017, by and among Precipio,&nbsp;Inc., the Creditors and Collateral Services, LLC (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;6, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex102.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.28</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517334319/d423153dex102.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Security Agreement, dated October&nbsp;31, 2017, by and between Precipio,&nbsp;Inc. and Collateral Services LLC, in its capacity as collateral agent for the Vendors (as defined therein) (incorporated by reference to Exhibit&nbsp;10.2 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;6, 2017). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.29</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000119312517340908/d461336dex101.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amendment, dated November&nbsp;9, 2017, to Placement Agency Agreement, dated November&nbsp;2, 2017, by and between Precipio,&nbsp;Inc. and Aegis Capital Corp. (incorporated by reference to Exhibit&nbsp;10.1 of the Company&rsquo;s Form&nbsp;8-K filed on November&nbsp;13, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.30</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of 8% Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on April 23, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.31</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Form 8-K filed on April 23, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.32</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Security Agreement by and among the Company and the investors named therein, dated April 20, 2018 (incorporated by reference to Exhibit 10.3 of the Company&rsquo;s Form 8-K filed on April 23, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.33</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418021669/tv491607_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement by and among the Company and the Purchasers named therein, dated April 20, 2018 (incorporated by reference to Exhibit 10.4 of the Company&rsquo;s Form 8-K filed on April 23, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.34</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Employment Agreement dated August 7, 2018 between the Company and Ilan Danieli (incorporated by reference to Exhibit 10.1(a) to the Company&rsquo;s Form 8-K filed on August 9, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.35</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Employment Agreement dated August 7, 2018 between the Company and Carl Iberger (incorporated by reference to Exhibit 10.1(b) to the Company&rsquo;s Form 8-K filed on August 9, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.36</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Employment Agreement dated August 7, 2018 between the Company and Ahmed Zaki Sabet (incorporated by reference to Exhibit 10.1(c) to the Company&rsquo;s Form 8-K filed on August 9, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1d.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.37</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1d.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Employment Agreement dated August 7, 2018 between the Company and Stephen Miller&nbsp;&nbsp;(incorporated by reference to Exhibit 10.1(d) to the Company&rsquo;s Form 8-K filed on August 9, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1e.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.38</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418043323/tv500569_ex10-1e.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Employment Agreement dated August 7, 2018 between the Company and Ayman Mohamed (incorporated by reference to Exhibit 10.1(e) to the Company&rsquo;s Form 8-K filed on August 9, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418049352/tv502827_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.39</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418049352/tv502827_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Purchase Agreement by and among the Company and Lincoln Park Capital Fund LLC dated September 7, 2018 (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on September 13, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418049352/tv502827_ex10-02.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.40</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418049352/tv502827_ex10-02.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Registration Rights Agreement, dated September 7, 2018, by and between Precipio, Inc. and Lincoln Park Capital Fund, LLC (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Form 8-K filed on September 13, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050129/tv503190_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.41</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050129/tv503190_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Exchange Agreement by and among the Company and the Purchasers named therein dated September 17, 2018 (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on September 20, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050129/tv503190_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.42</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050129/tv503190_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Form 8-K filed on September 20, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050756/tv503379_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.43</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418050756/tv503379_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Letter Agreement by and among the Company and the Investors named therein (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s form 8-K filed on September 25, 2018). </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.44</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amendment Agreement by and among the Company and the Purchasers named therein, dated November 29, 2018 (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on December 3, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.45</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of 8% Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 10.3 of the Company&rsquo;s Form 8-K filed on December 3, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.46</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Letter Agreement regarding repricing of warrants (incorporated by reference to Exhibit 10.3 of the Company&rsquo;s Form 8-K filed on December 3, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.47</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420418062935/tv508354_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock (incorporated by reference to Exhibit 10.4 of the Company&rsquo;s Form 8-K filed on December 3, 2018).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420419002284/tv511263_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.48</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420419002284/tv511263_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amendment and Restated Agreement dated January 15, 2019 (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on January 22, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">10.49</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form of Convertible Note (</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420419003827/tv512017_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">incorporated by reference to Exhibit 3.1 of the Company&rsquo;s Form 8-K filed on January 30, 2019</FONT></A><FONT STYLE="font-size: 10pt">). Settlement Agreement dated January 29, 2019 (</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000114420419003827/tv512017_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-K filed on January 30, 2019</FONT></A><FONT STYLE="font-size: 10pt">).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex104387647.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.50</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex104387647.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amendment No. 2 Agreement by and among the Company and the Purchasers named therein, dated April 16, 2019 (incorporated by reference to Exhibit 10.43 of the Company&rsquo;s Form 10-K filed on April 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex104400b0e.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.51</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex104400b0e.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of 8% Senior Secured Convertible Promissory Note relating to Amendment No. 2 Agreement (incorporated by reference to Exhibit 10.44 of the Company&rsquo;s Form 10-K filed on April 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex10451dedc.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.52</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019003039/prpo-20181231ex10451dedc.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock relating to Amendment No. 2 Agreement (incorporated by reference to Exhibit 10.45 of the Company&rsquo;s Form 10-K filed on April 16, 2019).</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex101800a5b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.53</FONT></A></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 93%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex101800a5b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form&nbsp;of 8% Senior Secured Convertible Promissory Note, dated May 14, 2019 (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Form 10-Q filed on May 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex1028084a3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.54</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex1028084a3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock dated May 14, 2019 (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Form 10-Q filed on May 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex103992299.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.55</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex103992299.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Security Agreement by and among the Company and the investors named therein, dated May 14, 2019 (incorporated by reference to Exhibit 10.3 of the Company&rsquo;s Form 10-Q filed on May 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex104e5e4d2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.56</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1043961/000155837019005135/prpo-20190331ex104e5e4d2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form of Securities Purchase Agreement by and among the Company and the Purchasers named therein, dated May 14, 2019. (incorporated by reference to Exhibit 10.4 of the Company&rsquo;s Form 10-Q filed on May 16, 2019).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tm2024208d1_ex21-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">21.1</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in">&nbsp;</TD>
    <TD><A HREF="tm2024208d1_ex21-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Subsidiaries of the Company.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tm2024208d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">23.1</FONT></A></TD>
    <TD STYLE="padding-left: 0.05in">&nbsp;</TD>
    <TD><A HREF="tm2024208d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent of Marcum&nbsp;LLP.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tm2024208d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">23.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2024208d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent of Sichenzia Ross Ference LLP (included in Exhibit 5.1)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="#POA" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">24.1*</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#POA" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Powers of Attorney (included on signature page)</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">This certification is not deemed &ldquo;filed&rdquo;
for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.
Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the
Securities Exchange Act of 1934, except to the extent that the Registrant specifically incorporates it by reference.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">#</TD><TD STYLE="text-align: justify">Confidential treatment has been requested or granted
for certain information contained in this exhibit. Such information has been omitted and filed separately with the Securities
and Exchange Commission.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&dagger;</TD><TD STYLE="text-align: justify">Indicates a management contract or any compensatory plan,
contract or arrangement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2024208d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 3.5in"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>Opinion of Sichenzia Ross Ference
LLP&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 26, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precipio, Inc.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4 Science Park&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New Haven, CT 06511</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
Registered under Registration Statement on Form S-1&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel
to you in connection with your filing of a Registration Statement on Form S-1 (File No. 333-_____) (as amended or supplemented,
the &ldquo;Registration Statement&rdquo;) pursuant to the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
relating to the registration of the offering by Precipio, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), of up to 4,500,000
shares (the &ldquo;Shares&rdquo;) of the Company&rsquo;s Common Stock, $0.01 par value per share, to be sold by the selling stockholder
listed in the Registration Statement under &ldquo;Selling Stockholder&rdquo; (the &ldquo;Selling Stockholder&rdquo;). The Shares
are being sold to the Selling Stockholder pursuant to the terms of that certain purchase agreement (the &ldquo;Purchase Agreement&rdquo;)
dated March 26, 2020 between the Company and the Selling Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have reviewed such
documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied,
without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth
below, on certificates of officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The opinion set forth
below is limited to the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the foregoing,
we are of the opinion that the shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance
with the terms of the Purchase Agreement, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to
the inclusion of this opinion as Exhibit 5.1 to the Registration Statement and to the references to our firm under the caption
 &ldquo;Legal Matters&rdquo; in the Registration Statement. In giving our consent, we do not admit that we are in the category of
persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">/s/ SICHENZIA ROSS FERENCE LLP</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">SICHENZIA ROSS FERENCE LLP</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>tm2024208d1_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSIDIARIES OF REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 50%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 49%; text-align: center"><FONT STYLE="font-size: 10pt"><B>State of Incorporation or Organization</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Precipio Diagnostics, Inc.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Precipio SPV, Inc.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>tm2024208d1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM&rsquo;S CONSENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference
in this Registration Statement of Precipio, Inc. on Form S-1 of our report, which includes an explanatory paragraph as to the Company&rsquo;s
ability to continue as a going concern, dated March 27, 2020, with respect to our audits of the consolidated financial statements
of Precipio, Inc. as of December 31, 2019 and 2018 and for the years ended December 31, 2019 and 2018, appearing in the Annual
Report on Form 10-K of Precipio, Inc. for the year ended December 31, 2019. We also consent to the reference to our firm under
the heading &ldquo;Experts&rdquo; in the Prospectus, which is part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our report on the consolidated financial
statements refers to a change in the method of accounting for ASC 842 <I>Leases</I> effective January 1, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 50%"><FONT STYLE="font-size: 10pt">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Hartford, CT</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">June 26, 2020 &nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 :0# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WQV55+$X
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M# 'Z8%4](US7/ _B&#0?$DYNM.N3MMKPDG;V')YQV(/2O5J\\^,44+>#DF?
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MKQSXISI)XFAB4\Q6XW?4DG^5=>$_BHBK\)PU>X?#FX-QX,M0W_+)WC'X'/\
M6O#Z]K^&D;1^#HB>CS.P^F<?TKJQG\-&='XCL:S]1US2])*#4+^WMB_*B5PN
M:OFO*?B%96^H_$KPU:74?F6\X"2)DC(+'/2O.A%2=F;O0[K_ (33PU_T&['_
M +^BC_A-/#7_ $&['_OZ*S?^%8^#_P#H#K_W]?\ ^*H_X5CX/_Z Z_\ ?U__
M (JJ_=]V&IH/XV\,QJ6;6[+ ZXDR?R%<#XF\43^/[E?#7AF*1[:1P;FZ8$#:
M/Y#^==>/AEX0!S_8Z?C*_P#C70Z?I5AI-M]GL+2*VB_NQKC/U]:%*$=8ZAKU
M&Z3IT.CZ3:Z? /W5O&$!]?4U#>^)=%TVY-O>ZG:V\P )CDD ('TK4Q7D-QHN
MGZ[\;-1L]2MQ/;^0'V%B.0BXZ&E!*3=P?D>A?\)IX:_Z#=C_ -_11_PFGAK_
M *#=C_W]%9O_  K'P?\ ] A?^_S_ /Q5!^&7@\?\P=?^_P _^-/]WW8:EVX\
M=^%[:(R/K5JP'9&W$_@*X*ZN[OXJ^([:WM8)8?#]E)OEE<8\P_X]@/>M%]$\
M"6/C2'P_+H12XDC#QRR2,8W)_AY/->CVMI;65ND%K!'#"OW4C7:!^%.ZAK$6
MKW)418U"*,*HP!Z"O,?A4X34/%+,0%6Z!)/;EJ]/KS#X5(LE_P"*4=0R-=88
M'N"6J8?#+Y#ZG7GQSX8!(.MVF1U^>C_A.O"__0;M/^^ZIGX:>$22?[&CY])'
M_P :/^%9^$/^@.G_ ']?_&A>S\PU-"W\9>';JXCMX-8M'ED.U%#\D^E;F:YB
MU^'OA6RNHKF#28UFB8.C%V.".AP373U,N7[(T!KS!E_MCXZ;9/FBTZV#(#V(
M'^+5Z>:\Q1AI?QUD\WY4U"U 0GN=H_JIJJ?7T$STZEHHJ$,**** "O-/C%_R
M#]%_Z_1_*O2Z\T^,7_(/T7_K]'\JTH_&A2V/2-P6,,2  ,DFL4^,_#:L5;6[
M($'!_>BM'4?^01=?]>[_ /H)KR?X9>#M!\0>'KBZU.P6XF6Z9 Q=E^7 XX(]
M:48JS;"YZ/\ \)IX:_Z#=E_W]%'_  FGAK_H-V/_ ']%9O\ PK'P?_T!U_[_
M #__ !5'_"L?!_\ T!U_[^O_ /%4_P!WW8:B:O\ $KPUI=JTB7Z7<N/EAM_F
M+'Z]!6%X&TG4M;\1W'C/683$TBE+2$CHO3/T X_.NIL/ ?AC39Q/;:/ )%Z,
M^7Q_WT371A1C & *7-%*T0,/QG_R)FL?]>K_ ,JROA?_ ,D\TS_MI_Z&U:OC
M/_D3-8_Z]7_E65\+_P#DGNF?]M/_ $-J?_+OYAU,'0D_M;XT:U=R_,+"/RX_
M]GHH_K^=>H5YAX>;^S/C-KMG+\IO8_,C]^C?XUZ?15W7H@04445F,*Q?%M@F
MI>$]3M7 .ZW<CZ@9'ZBMJL?Q3>II_A74[EV "6SX^I&!^IIK= S!^%-X]WX#
MM0YR8)'B!]@<C^=%-^$]J]KX#MF<8\^6249]"<?THJJGQL2V.W->2?&O2V:+
M3=51<A"T$AQZ\C^M>N5C^)]$C\1>'KO39, RI^[8_P +CE3^=*G+EDF#5U8^
M6Z569'5U.&4Y!'8BI;JUFLKN:UN$,<\+E'4]B#4->F8'TKX'\4P>)M!BFW@7
MD2A+B//(;U^AZUTP((XKYH\#27Z>*[06-\+(LP$LKGY=G<$=#GTKZ64\#'(]
M?6O/K4^26AM%W0ZBF[O:LK5?$VDZ/$7O+R)6'2-6W.?P%9I-Z(J]B]>WL&GV
M<MW<N$AB4LS&OGO6M3DUC6+J_DZS/E1Z+V'Y8K9\7>,[GQ)*(8U,%@ARL6>7
M/JW^%<O7I8:A[-<TMSFJSOHA0"S!5&6)P!7T-X<T_P#LOP[8V9&&CB&[_>/)
M_4UY-\/_  \VL:XMU*F;2T(=B>C/_"/ZU[;U%88RI=J*+I1LKBUYAXU_Y*KX
M3^H_]#KT\\5YCXV_Y*GX3./XA_Z%7/2^+[S66QZ=12"EK,84444 )7F5A_R7
MG4/^O4?^@+7IO2O,K'/_  OC4/\ KU'_ * M7#KZ"9Z;2TE+4(9P?Q.\/2:C
MH\>KV((U'3#YJ,G4H.2/PQFMWPAXAB\3>';:_4@38V3*/X7'7_'\:W64,,'E
M2,$'O7E6FA_ /Q*?32#_ &1K#9A]$<GC\CQ]"*T7O1MU0MF>K5YE\)_^0EXG
M_P"OL?S:O32<5XKX&\7Z/X9U/7QJ<[QF>ZS'M0MG!;/3ZT4TW&20-ZGM=%<1
M_P +9\)?\_DW_?EJ/^%L^$O^?V;_ +\-2]E/L%T=O17$?\+9\)?\_LW_ 'X:
MC_A;/A+_ )_)O^_+4>SGV"Z.WKS[XGZ%<SVEKX@TP'[?I;;_ )>I3.?QP>?I
MFNTTK5;36M.AO[&3S+:8$HV".AP>/K5MD#9!Z="".M2I<KN,P_"OB6T\3Z-%
M>V[*)1A9XL\QOW'T]*WLUYGK7@;5-#U5]<\&3>5(W,MD3\K^N >"/8_A19_%
MI+-A;>(]'N[&Y7AF1,J3]#@_SJ_9WUAJA7[GIE%<,/BWX3(YNIQ[>2:7_A;7
MA/\ Y^Y_^_!H]E/L%T=Q7FGQB_Y!^B_]?H_E75^'O&>B^)YYH-,G=Y85WNK1
ME>,XS7)_&+_D':+Q_P OH_E3I:5$F#V/0;__ )!5S_UP;_T$UP?P:_Y%.[_Z
M_7_]!6N\OAG3+D?],6_]!-<'\&_^14O/^OU__05I)^X_D'5'HXHHHK,84444
M 8?C/_D3-8_Z]7_E65\+?^2>Z9_VT_\ 0S6KXRY\&:QC_GU?^597PN_Y)[IO
M_;3_ -#:M/\ EW\Q=3(^)>E7=E>6'B[3%)N+!@)U4=4SU^G4'V-=EX?UZR\1
M:3#J%FX*N/G3/,;=U-:4D22HR2*&1AAE(R"/2O,M2\%ZWX5U236/!LNZ%SF6
MP<Y!'H >H_44*TURO=!LSU '-+7FEG\7;6!O(U[2;RPN1PVU,C/T.#5V;XO^
M%XXRT;W<S=E6'_$TO9R[!='>DBO*_'FK2>*M:MO!NCOY@,@:\E3E5 [9]NI]
M\4V?Q-XN\;AK/P_ILFFV+\/=S<''U_PS78>$?!EEX5LF6)O.O)>9[EAR_L/0
M527L_>>X;F]I]E#IVG6]E N(H(Q&H]@**LC@45D,*0C-+10!YE\3/ 3:NK:U
MI46;V-?WT*CF51W'^T/UKQ((YD\O:=^=NTCG/I7UU7/-X-T5O$*ZY]C0784@
MX^ZQ/\17IGWKHI5^569$HWV/"K&U%I;A>KGEC[UT.G>*-9TI EM?/Y8Z1R?.
MOY&O0]:^'NFZBS36;&SF/4*,H3].WX5Q]Y\.]=MF/DI%<H.AC?!_(ULJM.:U
M."=*M&5T8>O>)M3UB:)[B<H43;B$E 1G/(!K"))))))]2:TM6TF_TZ[2"ZM9
M(Y2N[;C/'X4MEX;UG4& MM-N7!_B*;1^9KJAR1@FC6/,U9[F76OH'AZ]\0WP
MM[5"(P?WLS#Y4'^/M78Z)\+)G*RZS<!$ZF"$Y)^K5Z38:=:Z7:I;6<"0PKT5
M1^I]:PK8N*TAJS6%)]2#1=(M=$TV.QM$Q&G5CU8]R:TJ**\YZN[.@*AEM+::
M>*>6"-Y8L^6[*"R9]#VJ:B@! ,"EHHH **** "H1:6PNFNA!&+AEVF7:-Q'I
MGKBIJ* "BBB@ J&6TMYY(Y)H(Y'B;=&S*"4/J/2IJ* $K+D\-:'-*TLFCV+R
M.=S,T"DD^IXK5HHV R/^$7T#_H"Z?_X#I_A1_P (OH'_ $!=/_\  =/\*UZ*
M=V*R,C_A%] _Z NG_P#@.G^%'_"+Z!_T!=/_ / =/\*UZ*+L+(BM[:"T@6"W
MA2*)!A4C4*!] *EHHI#$P*AN+2VNTV7-O%,OI(@8?K4]%*P&5_PC6AGG^Q[#
M_P !U_PI/^$9T+_H#6'_ (#K_A6M1578K(IV6E:?I[,UE96]NS\,8HPI/UQ4
MUQ:6]VJK<01S!&#*)%#8(Z$9[U-12&(0""*BM[6WM(S';01PH26*QJ%&3U/%
M344 %%%% !1110 UT26-HY%#HPPRL,@BF06\-K"L-O$D42C"HBX ^@%2T4 %
M)BEHH KW-E:7B[;FVAF'I(@;^=58M!TB"0/%I=FCCHRP*#_*M*BB[[@(%
/  '0"@#%+10 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
